3-Vinylcyclopentanon | 50337-14-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-Vinylcyclopentanon
• 英文别名: 3-vinylcyclopentanone；3-Ethenylcyclopentan-1-one
• CAS: 50337-14-9
• 化学式: C₇H₁₀O
• 分子量: 110.156
• InChiKey: JORKABJLEXAPFV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  8
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3-Vinylcyclopentanon 在 tris(dibenzoylmethano)iron(III) samarium diiodide 、 氢溴酸 、 sodium iodide 作用下， 以 四氢呋喃 、 正己烷 、 丙酮 为溶剂， 反应 14.0h， 生成 1-norbornyl alcohol
  参考文献：
  名称：

  A facile synthesis of bicyclo[m.n.1]alkan-1-ols. Evidence for organosamarium intermediates in the samarium(II) iodide promoted intramolecular Barbier-type reaction

  摘要：

  Samarium(II) iodide (SmI2) has been successfully employed as a reductive coupling agent for the intramolecular Barbier-type synthesis of bicyclo[m.n.1]alkan-1-ols. Thus, a variety of 3-(omega-iodoalkyl)cycloalkanones, upon treatment with SmI2 and a catalytic quantity of iron complex in tetrahydrofuran (THF), provide the title compounds in excellent yields. The reaction is quite general for the construction of diverse bicyclic ring systems, including the highly strained bicyclo[2.1.1]hexan-1-ol. In addition to exploring the synthetic utility of this reaction, studies have been performed which provide insight on the mechanistic details of the SmI2-promoted intramolecular Barbier-type synthesis. Compelling evidence for the intermediacy of organosamarium species has thus been gathered.

  DOI：

  10.1021/jo00013a008
• 作为产物：
  描述：

  3-ethenyl-1-trimethylsiloxycyclopent-1-ene 在 盐酸 作用下， 生成 3-Vinylcyclopentanon
  参考文献：
  名称：

  A facile synthesis of bicyclo[m.n.1]alkan-1-ols. Evidence for organosamarium intermediates in the samarium(II) iodide promoted intramolecular Barbier-type reaction

  摘要：

  Samarium(II) iodide (SmI2) has been successfully employed as a reductive coupling agent for the intramolecular Barbier-type synthesis of bicyclo[m.n.1]alkan-1-ols. Thus, a variety of 3-(omega-iodoalkyl)cycloalkanones, upon treatment with SmI2 and a catalytic quantity of iron complex in tetrahydrofuran (THF), provide the title compounds in excellent yields. The reaction is quite general for the construction of diverse bicyclic ring systems, including the highly strained bicyclo[2.1.1]hexan-1-ol. In addition to exploring the synthetic utility of this reaction, studies have been performed which provide insight on the mechanistic details of the SmI2-promoted intramolecular Barbier-type synthesis. Compelling evidence for the intermediacy of organosamarium species has thus been gathered.

  DOI：

  10.1021/jo00013a008

文献信息

• Arginase Inhibitors and Their Therapeutic Applications
  申请人：OncoArendi Therapeutics S.A.

  公开号：US20170319536A1

  公开（公告）日：2017-11-09

  Disclosed are small molecule therapeutic compounds that are potent inhibitors of arginase 1 and arginase 2 activity. Also disclosed are pharmaceutical compositions comprising the compounds, and methods for using the compounds for treating or preventing a disease or condition associated with arginase activity.

  揭示了一种小分子治疗化合物，它们是较强的精氨酸酶1和精氨酸酶2活性抑制剂。还揭示了包含这些化合物的药物组合物，以及使用这些化合物治疗或预防与精氨酸酶活性相关的疾病或状况的方法。
• Unusual products from dirhodium tetraacylate-catalyzed decomposition of diazoacetylcycloalkanes
  作者：Paolo Ceccherelli、Massimo Curini、Maria Carla Marcotullio、Emanuela Pisani、Ornelio Rosati、Ernest Wenkert

  DOI：10.1016/s0040-4020(97)00507-3

  日期：1997.6

  Rh2(OAc)4-assisted decompositions of diazoacetylcycloalkanes are shown to yield cycloalkylacetic acids (Wolff rearrangement), unexpected cycloalkylcarboxylic acids and bicyclic ketones (intramolecular CH bond insertion). Rh2(OCOCF3)4-promoted reactions, on the other hand, have furnished bicyclic ketones and ketene dimers.

  重氮基乙酰基环烷烃的Rh 2（OAc）4辅助分解显示可产生环烷基乙酸（沃尔夫重排），意外的环烷基羧酸和双环酮（分子内CH键插入）。另一方面，Rh 2（OCOCF 3）4促进的反应提供了双环酮和烯酮二聚体。
• Intramolecular Azide-Alkene 1,3-Dipolar Cycloaddition/Enamine Addition(s) Cascade Reaction: Synthesis of Nitrogen-Containing Heterocycles
  作者：Irene de Miguel、Bernardo Herradón、Enrique Mann

  DOI：10.1002/adsc.201200071

  日期：2012.6.18

  A cascade intramolecular azide‐alkene 1,3‐dipolar cycloaddition/1,2 enamine and/or 1,4 enamine addition reaction sequence has been developed, and provides access to a variety of nitrogen containing heterocycles from readily available ω‐azido alkenes.

  已经开发出一种级联的分子内叠氮化物-烯烃1,3-偶极环加成/ 1,2，-烯胺和/或1,4-烯胺加成反应序列，并提供了从容易获得的ω-叠氮基烯烃中获得各种含氮杂环的途径。
• [EN] MODIFIED IONIC LIQUIDS CONTAINING PHOSPHORUS<br/>[FR] LIQUIDES IONIQUES MODIFIÉS CONTENANT DU PHOSPHORE
  申请人：NOHMS TECH INC

  公开号：WO2017173323A1

  公开（公告）日：2017-10-05

  The present disclosure is directed to a phosphorus-modified ionic liquid compound, the synthesis thereof and an electrochemical cell electrolyte containing the phosphorus-modified ionic liquid compound.

  本公开涉及一种磷改性离子液体化合物，其合成方法以及含有该磷改性离子液体化合物的电化学电池电解质。
• [EN] NOVEL MONOCYCLIC AND BICYCLIC RING SYSTEM SUBSTITUTED CARBANUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS<br/>[FR] NOUVEAUX ANALOGUES DE CARBANUCLÉOSIDE SUBSTITUÉS PAR UN SYSTÈME CYCLIQUE, MONOCYCLIQUE ET BICYCLIQUE DESTINÉS À ÊTRE UTILISÉS EN TANT QU'INHIBITEURS DE PRMT5
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2018065365A1

  公开（公告）日：2018-04-12

  The present invention relates to novel novel monocyclic and bicyclic ring system substituted carbanucleoside analogues of Formula (I), wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as PRMT5 inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

  本发明涉及一种新的单环和双环环系统取代的碳核苷类似物，化学式为（I），其中变量的含义如权利要求中所定义。根据本发明的化合物可用作PRMT5抑制剂。本发明还涉及包含所述化合物作为活性成分的药物组合物，以及将所述化合物用作药物的用途。